Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients

Lara C. Pullen, PhD  |  January 2, 2013

In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.

Molecular Analysis Reveals Potential Treatment Window for Systemic Juvenile Idiopathic Arthritis

Lara C. Pullen, PhD  |  January 2, 2013

In patients with simultaneous systemic and arthritic components of systemic juvenile idiopathic arthritis (SJIA), these components appear to be related mechanistically. Moreover, the inflammatory pathways of SJIA appear to be distinct from those seen in polyarticular JIA.

BU’s New ENACT Arthritis Research Training and Outreach Program Off to Successful Start

Michael O’Neal  |  December 3, 2012

A new research training program at the Boston University is making a profound impact on the Greater Boston arthritis community.

Therapies Aimed at Immune Cell Progenitors May Be Key to Reducing Post Myocardial Infarction Risk

Lara C. Pullen, PhD  |  November 9, 2012

Researchers have identified hematopoietic stem and progenitor cells that are liberated from bone marrow niches by a myocardial infarction.

Gadolinium Compounds Provide Insights into Pathogenesis of Fibrosing Diseases

Lara C. Pullen, PhD  |  November 9, 2012

Toll-like receptors appear to play an important role in the pathogenesis of fibrotic disorders including nephrogenic systemic fibrosis and systemic sclerosis.

Rheumatologists Seek Public Vote for Research Grant Award

Michael O’Neal  |  October 17, 2012

Brigham and Women’s docs compete for BRIght Futures Prize for personalized medicine research

South Korea Okays First Officially Approved Monoclonal Antibody for RA

Kurt Ullman  |  October 17, 2012

11 Products Looking for U.S. Marketing Nod

Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis

Lara C. Pullen, PhD  |  August 30, 2012

Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.

Newly Discovered Molecule Modulates Cartilage Repair

Lara C. Pullen, PhD  |  August 29, 2012

Chondrocytes play an important role in cartilage repair as well as symptom relief. Research published in Science provides insights into the role of stem cell–based therapies in the promotion of chondrogenesis and cartilage repair.

ACA Upheld: What Does This Mean for Rheumatology?

Richard Quinn  |  August 17, 2012

What does the Supreme Court decision to uphold the Affordable Care Act mean for rheumatologists?

  • « Previous Page
  • 1
  • …
  • 320
  • 321
  • 322
  • 323
  • 324
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences